Table 3.
Anesthetic Considerations and Management of Research-Related Procedures
| No. (%) | ||
|---|---|---|
| Anesthesia-Related Variables | First Anesthetic Procedure for Each Patient |
All Anesthetic Procedures for All Patients |
| Abnormal airwaya | 45 (7) | 171 (12) |
| Induction agent | ||
| Sevoflurane and nitrous oxide | 228 (38) | 469 (32) |
| Propofol | 378 (62) | 1007 (68) |
| Ketamine | 1 (0.2) | 2 (0.1) |
| Etomidate | 0 | 1 (0.1) |
| Sodium thiopental | 0 | 1 (0.1) |
| Maintenance anesthetic drugs | ||
| Propofol | 605 (99.7) | 1476 (99.7) |
| Propofol/sevoflurane | 2 (0.3) | 4 (0.3) |
| Airway management | ||
| Endotracheal tube | 40 (6.6) | 94 (6.4) |
| Laryngeal mask airway | 23 (3.8) | 66 (4.5) |
| Oral or nasal airway | 20 (3.3) | 39 (2.6) |
| Muscle relaxant during anesthesia | 26 (4) | 61 (4) |
| Anesthetic duration, mean (SD), min | 122 (59) | 115 (55) |
| Time in PACU, mean (SD), min | 41 (20) | 40 (21) |
Abbreviation: PACU, postanesthesia care unit.
a
Abnormal airway resulting from congenital craniofacial deformities and/or as result of primary disease.